Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 74,607 | 79,078 | 67,335 | 70,934 | 69,283 |
| Cost of Goods | 22,885 | 21,295 | 18,228 | 23,811 | 24,581 |
| Gross Profit | 51,722 | 57,783 | 49,107 | 47,123 | 44,702 |
| Operating Expenses | 59,544 | 49,613 | 52,907 | 63,714 | 59,333 |
| Operating Income | -6,937 | 8,465 | -3,572 | -15,780 | -14,050 |
| Interest Expense | 5,157 | 5,105 | 5,127 | 5,226 | 2,589 |
| Other Income | 1,449 | 1,270 | 1,147 | 1,293 | -3,197 |
| Pre-tax Income | -10,645 | 4,630 | -7,552 | -19,713 | -19,836 |
| Income Tax | 35 | 35 | 45 | 30 | 30 |
| Net Income Continuous | -10,680 | 4,595 | -7,597 | -19,743 | -19,866 |
| Net Income | $-10,680 | $4,595 | $-7,597 | $-19,743 | $-19,866 |
| EPS Basic Total Ops | -0.26 | 0.13 | -0.19 | -0.49 | -0.52 |
| EPS Basic Continuous Ops | -0.26 | 0.13 | -0.19 | -0.49 | -0.52 |
| EPS Diluted Total Ops | -0.26 | 0.13 | -0.19 | -0.49 | -0.52 |
| EPS Diluted Continuous Ops | -0.26 | 0.13 | -0.19 | -0.49 | -0.52 |
| EBITDA(a) | $-671 | $15,546 | $3,152 | $-8,764 | $-9,367 |